Literature DB >> 32533519

Assessment of the Effect of Perioperative Venous Lidocaine on the Intensity of Pain and IL-6 Concentration After Laparoscopic Gastroplasty.

Caio Marcio Barros de Oliveira1, Lais Maria Gaspar Coelho1, José Aparecido Valadão1, Ed Carlos Rey Moura1, Antônio Augusto Moura da Silva1, Roclides Castro de Lima1, Milena Karina Coló Brunialti2, Reinaldo Salomão2, Plinio da Cunha Leal1, Rioko Kimiko Sakata3.   

Abstract

BACKGROUND AND OBJECTIVES: Opioids are associated with sedation and respiratory depression. The primary objective of this study was to assess pain intensity after gastric bypass with lidocaine. The secondary objective was to assess the IL-6 concentration, consumption of morphine, time to morphine request, time to extubation, and side effects.
METHODS: Sixty patients aged 18 to 60 years, with ASA (American Society of Anesthesiologists) scores of 2 or 3, who underwent bariatric surgery were allocated to two groups. Patients in group 1 were administered lidocaine (1.5 mg/kg) 5 min before the induction of anesthesia, and group 2 was administered 0.9% saline solution in an equal volume. Subsequently, lidocaine (2 mg/kg/h) or 0.9% saline was infused during the entire surgical procedure. Anesthesia was performed with fentanyl (5 μg/kg), propofol, rocuronium, and sevoflurane. Postoperative patient-controlled analgesia was provided with morphine. The following were evaluated: pain intensity, IL-6, 24-h consumption of morphine, time to the morphine request, time to extubation, and adverse effects.
RESULTS: The lidocaine group had a lower pain intensity than the saline group for up to 1 h, with no differences between groups in IL-6 and time to extubation. The lidocaine group consumed less morphine within 24 h, had a longer time until the first supplemental morphine request, and had a lower incidence of nausea.
CONCLUSIONS: Lidocaine reduced the intensity of early postoperative pain, incidence of nausea, and consumption of morphine within 24 h and increased time to the first morphine request, without reducing the plasma concentrations of IL-6.

Entities:  

Keywords:  Analgesia; Gastroplasty; Interleukin-6; Lidocaine; Postoperative pain

Mesh:

Substances:

Year:  2020        PMID: 32533519     DOI: 10.1007/s11695-020-04748-1

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  3 in total

1.  Effects of Systemic Lidocaine on Postoperative Recovery Quality and Immune Function in Patients Undergoing Laparoscopic Radical Gastrectomy.

Authors:  Xueli Lv; Xiaoxiao Li; Kedi Guo; Tong Li; Yuping Yang; Wensi Lu; Shuting Wang; Su Liu
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

2.  Effect of Systemic Lidocaine on Postoperative Early Recovery Quality in Patients Undergoing Supratentorial Tumor Resection.

Authors:  Kai Zhao; Yushan Dong; Gaowei Su; Yaolin Wang; Tao Ji; Nanling Wu; Xiaojie Cui; Wenzhan Li; Yanming Yang; Xiuxia Chen
Journal:  Drug Des Devel Ther       Date:  2022-04-22       Impact factor: 4.319

3.  Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial.

Authors:  Yan Xu; Mao Ye; Ying Hong; Yi Kang; Yue Li; Xiao Xiao; Li Zhou; Chunling Jiang
Journal:  J Pain Res       Date:  2021-12-01       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.